Increased Expression of Angiogenin in Hepatocellular Carcinoma in Correlation with Tumor Vascularity

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4852-4859

  Hisai, Hiroyuki ^a   Kato, Junji ^a   Kobune, Masayoshi ^a   Murakami, Tsuzuku ^a   Miyanishi, Koji ^a   Takahashi, Minoru ^a   Yoshizaki, Naohito ^a   Takimoto, Rishu ^a   Terui, Takeshi ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANGIOGENIN; MESSENGER RNA; POLYPEPTIDE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD SAMPLING; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELIAC ANGIOGRAPHY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTION; KAPLAN MEIER METHOD; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MICROVASCULATURE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SURVIVAL RATE; TISSUE LEVEL; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RIBONUCLEASE, PANCREATIC; RNA, MESSENGER; TIME FACTORS;

EID: 10744220077     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Freeny, P. C., and Marks, W. N. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT. Radiology, 160: 613-618, 1986.
2. Bhattacharya, S., Davidson, B., and Dhillon, A. P. Blood supply of early hepatocellular carcinoma. Semin. Liver Dis., 15: 390-401, 1995.
3. Miura, H., Miyazaki, T., Kuroda, M., Oka, T., Machinami, R., Kadama, T., Shibuya, M., Makuuchi, M., Yazaki, Y., and Ohnishi, S. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J. Hepatol., 27: 854-861, 1997.
4. Torimura, T., Sata, M., Ueno, T., Kin, M., Tsuji, R., Suzaku, K., Hashimoto, O., Sugawara, H., and Tanikawa, K. Increased expression of vascular endothelial growth factor in associated with tumor progression in hepatocellular carcinoma. Hum. Pathol., 29: 986-991, 1998.
5. Poon, R. T., Ng, I. O., Lau, C., Zhu, L. X., Yu, W. C., Lo, C. M., Fan, S. T., and Wong, J. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann. Surg., 223: 227-235, 2001.
6. Jin-no, K., Tanimizu, M., Hyodo, I., Nishikawa, Y., Hosokawa, Y., Endo, H., Doi, T., Mandai, K., and Ishizuka, H. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients. Cancer (Phila.), 82: 1260-1267, 1998.
7. Poon, R. T., Ng, I. O., Lau, C., Yu, W., Fan, S. T., and Wong, J. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am. J. Surg., 182: 298-304, 2001.
8. El-Assal, O. N., Yamanoi, A., Soda, Y., Yamaguchi, M., Igarashi, M., Yamamoto, A., Nabika, T., and Ngasue. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology, 27: 1554-1562, 1998.
9. Shimada, M., Hasegawa, H., Rikimaru, T., Gion, T., Hamatsu, T., Yanashita, Y., Shirabe, K., and Sugimachi, K. The significance of thymidine phosphorylase activity in hepatocellular carcinoma and chronic diseased livers: a special reference to liver fibrosis and multicentric tumor occurrence. Cancer Lett., 148: 165-172, 2000.
10. Mise, M., Arii, S., Higashitsuji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., Fujita, J., and Imamura, M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumors. Hepatology, 23: 455-464, 1996.
11. Weiner, H. L., Weiner, L. H., and Swain, J. L. Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science (Washington DC), 237: 280-282, 1987.
12. Burgmann, H., Hollenstein, U., Maca, T., Zedwitz-Liebenstein, K., Thalhammer, F., Koppensteiner, R., Ehringer, H., and Graninger, W. Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. J. Clin. Pathol., 49: 508-510, 1996.
13. Malamitsi-Puchener, A., Sarandakou, A., Dafogianni, C., Tziotis, J., and Bartsocas, C. S. Serum angiogenin levels in children and adolescents with insulin-dependent diabetes mellitus. Pediatr. Res., 43: 798-800, 1998.
14. Shimoyama, S., Yamasaki, K., Kawahara, M., and Kaminishi, M. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin. Cancer Res., 5: 1125-1130, 1999.
15. Shimoyama, S., Gansauge, F., Gansauge, S., Negri, G., Oohara, T., and Beger, H. G. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res., 56: 2703-2706, 1996.
16. Miyake, H., Hara, I., Yamanaka, K., Gohji, K., Arakawa, S., and Kamidono, S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients in related to disease progression and recurrence. Cancer (Phila.), 86: 316-324, 1999.
17. Hartmann, A., Kunz, M., Köstlin, S., Gillitzer, R., Toksoy, A., Bröcker, E. B., and Klein, C. E. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res., 59: 1578-1583, 1999.
18. Barton, D. P. J., Cai, A., Wendt, K., Young, M., Gamero, A., and De Cesare, S. Angiogenic protein expression in advanced epithelial ovarian cancer. Clin. Cancer Res., 3: 1579-1586, 1997.
19. Montero, S., Guzmán, C., Cortés-Funes, H., and Colomer, R. Angiogenin expression and prognosis in primary breast carcinoma. Clin. Cancer Res., 4: 2161-2168, 1998.
20. Sobin, L. H., and Wittekind, Ch. TNM Classification of Malignant Tumours, UICC, ed. 5, pp. 74-77. New York: Wiley-Liss, 1997.
21. Honda, H., Ochiai, K., Adachi, E., Yasumori, K., Hayashi, T., Kawashima, A., Fukuya, T., Gibo, M., Matsumata, T., Tsuneyoshi, M., and Masuda, K. Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings. Radiology, 189: 857-862, 1993.
22. Edmondson, H. A., and Steiner, P. E. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer (Phila.), 7: 462-503, 1954.
23. Shi, S., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues; an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
24. Kato, J., Kobune, M., Nakamura, T., Kuroiwa, G., Takada, K., Takimoto, R., Sato, Y., Fujikawa, K., Takahashi, M., Takayama, T., Ikeda, T., and Niitsu, Y. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res., 61: 8697-8702, 2001.
25. Shina, S., Tagawa, K., Unuma, T., and Terano, A. Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. Am. J. Roentgenol., 154: 1989, 947-951.
26. Tanigawa, N., Lu, C., Mitsui, T., and Miura, S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 26: 1216-1223, 1997.
27. Park, Y. N., Kim, Y., Yang, K. M., and Park, C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch. Pathol. Lab. Med., 124: 1061-1065, 2000.
28. Morinaga, S., Imada, T., Shimizu, A., Akaike, M., Sugimasa, Y., Takemiya, S., and Takanashi, Y. Angiogenesis in hepatocellular carcinoma as evaluated by α smooth muscle actin immunohistochemistry. Hepatogastroenterology, 48: 224-228, 2001.
29. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene expression by hypoxia-inducible factor-1. Mol. Cell. Biol., 16: 4604-4613, 1996.
30. Yamaguchi, R., Yano, H., Iemura, A., Ogasawara, S., Haramaki, M., and Kojiro, M. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology, 28: 68-77, 1998.
31. Shapiro, R., Strydom, D. J., Olson, K. A., and Vallee, B. L. Isolation of angiogenin from normal human plasma. Biochemistry, 26: 5141-5146, 1987.
32. Poon, R. T., Ng, I. O., Lau, C., Yu, W. C., Yang, Z. F., Fan, S. T., and Wong, J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin. Oncol., 20: 1775-1785, 2002.
33. Olson, K. A., French, T. C., Vallee, B. L., and Fett, J. W. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res., 54: 4576-4579, 1994.
34. Piccoli, R., Olson, K. A., Vallee, B. L., and Fett, J. W. Chimetric anti-angiogenin antibody cAb 26-2F inhibits the formation of human breast cancer xenografts in athymic mice. Proc. Natl. Acad. Sci. USA, 95: 4579-4583, 1998.
35. Olson, K. A., Fett, J. W., French, T. C., Key, M. E., and Vallee, B. L. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 92: 442-446, 1995.
36. Olson, K. A., Beyers, H. R., Key, M. E., Fett, J. W. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int. J. Cancer, 98: 923-929, 2002.